Funder
Coalition for Epidemic Preparedness Innovations
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference34 articles.
1. FDA. Patient-focused drug development glossary. https://www.fda.gov/drugs/development-approval-process-drugs/patient-focused-drug-development-glossary [accessed 22 9 2022].
2. Structured frameworks to increase the transparency of the assessment of benefits and risks of medicines: current status and possible future directions;Pignatti;Clin Pharmacol Ther,2015
3. Development of a framework for enhancing the transparency, reproducibility and communication of the benefit-risk balance of medicines;Coplan;Clin Pharmacol Ther,2011
4. Application of the BRAT framework to case studies: observations and insights;Levitan;Clin Pharmacol Ther,2011
5. FDA. Benefit-risk assessment for new drug and biological products: draft. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/benefit-risk-assessment-new-drug-and-biological-products. [accessed 22 9 2022].
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献